MX2021015155A - Polisacaridos de ramnosa. - Google Patents

Polisacaridos de ramnosa.

Info

Publication number
MX2021015155A
MX2021015155A MX2021015155A MX2021015155A MX2021015155A MX 2021015155 A MX2021015155 A MX 2021015155A MX 2021015155 A MX2021015155 A MX 2021015155A MX 2021015155 A MX2021015155 A MX 2021015155A MX 2021015155 A MX2021015155 A MX 2021015155A
Authority
MX
Mexico
Prior art keywords
polysaccharide
glycoconjugate
streptococcal
rhamnose
vaccine
Prior art date
Application number
MX2021015155A
Other languages
English (en)
Inventor
Helge Dorfmueller
Original Assignee
Univ Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dundee filed Critical Univ Dundee
Publication of MX2021015155A publication Critical patent/MX2021015155A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01288—Galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase (2.4.1.288)

Abstract

La presente invención se refiere a un método para sintetizar un polisacárido de ramnosa. La invención también se refiere a un polisacárido estreptocócico sintético, un glucoconjugado estreptocócico, una composición inmunogénica o vacuna que comprende el polisacárido o glucoconjugado estreptocócico y el polisacárido, glucoconjugado, composición inmunogénica o vacuna para su uso en el desarrollo de una respuesta inmunitaria en un animal o para su uso en el tratamiento o prevención de una enfermedad, afección o infección de etiología estreptocócica.
MX2021015155A 2019-06-13 2020-06-12 Polisacaridos de ramnosa. MX2021015155A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1908528.1A GB201908528D0 (en) 2019-06-13 2019-06-13 Rhamnose-polysaccharides
PCT/EP2020/066314 WO2020249737A1 (en) 2019-06-13 2020-06-12 Rhamnose-polysaccharides

Publications (1)

Publication Number Publication Date
MX2021015155A true MX2021015155A (es) 2022-04-06

Family

ID=67432203

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021015155A MX2021015155A (es) 2019-06-13 2020-06-12 Polisacaridos de ramnosa.

Country Status (12)

Country Link
US (1) US20220259629A1 (es)
EP (1) EP3983555A1 (es)
JP (1) JP2022536703A (es)
KR (1) KR20220035377A (es)
CN (1) CN114555817A (es)
AU (1) AU2020293566A1 (es)
BR (1) BR112021024189A2 (es)
CA (1) CA3141172A1 (es)
GB (1) GB201908528D0 (es)
IL (1) IL288837A (es)
MX (1) MX2021015155A (es)
WO (1) WO2020249737A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115078562B (zh) * 2022-05-06 2023-09-05 天津中医药大学 一种红参寡糖同系物的制备方法与结构表征方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3110441T3 (fi) * 2014-02-24 2024-05-06 Glaxosmithkline Biologicals S A Uusi polysakkaridi ja sen käyttöjä
GB201711637D0 (en) * 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition

Also Published As

Publication number Publication date
KR20220035377A (ko) 2022-03-22
EP3983555A1 (en) 2022-04-20
JP2022536703A (ja) 2022-08-18
US20220259629A1 (en) 2022-08-18
AU2020293566A1 (en) 2022-01-20
IL288837A (en) 2022-02-01
GB201908528D0 (en) 2019-07-31
BR112021024189A2 (pt) 2022-01-11
CA3141172A1 (en) 2020-12-17
WO2020249737A1 (en) 2020-12-17
CN114555817A (zh) 2022-05-27

Similar Documents

Publication Publication Date Title
PH12017501898A1 (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MX2021015775A (es) Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados, kits que las comprenden y sus usos.
WO2017143024A8 (en) Pathogen vaccines and methods of producing and using the same
BR112018007812A2 (pt) polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica.
MX2018010586A (es) Nanovacuna de activacion de "sting" para inmunoterapia.
EA035991B9 (ru) Новый полисахарид и его применения
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
MX2019008564A (es) Composiciones inmunogenicas para su uso en vacunas neumococicas.
PH12020500080A1 (en) Senecavirus a immunogenic compositions and methods thereof
EP4272750A3 (en) Protein antigens that provide protection against pneumococcal colonization and/or disease
WO2017214596A8 (en) Compositions and methods for preventing and treating zika virus infection
MX2019005423A (es) Conjugado proteico de polisacarido inmunogenico que comprende un polisacarido derivado de estreptococo grupo b (gbs).
MX2020008454A (es) Composicion inmunogenica que comprende antigenos estafilococicos.
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
TN2019000064A1 (en) Composition comprising multivalent capsular polysaccharide-transport protein and use thereof
PH12018501205A1 (en) Synthetic vaccines against streptococcus pneumoniae serotype 2
MX2021015155A (es) Polisacaridos de ramnosa.
PH12017500407A1 (en) Streptococcus agalactiae antigens associated with strains virulent in fish
MX2022015860A (es) Inmunizacion bacteriana que utiliza una vacuna con nanoparticulas.
MX2019013779A (es) Vacuna que comprende toxoides de clostridium.
MX2022001937A (es) Composicion inmunogenica.
WO2019157188A3 (en) Compositions and methods for cross-protection against pneumococcal disease
MY190074A (en) A monovalent vaccine formulation and a method for preparation thereof
UA33502A (uk) Спосіб виготовлення інактивованої вакцини проти сальмонельозів тварин